Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Anagenics ( (AU:AN1) ) has shared an update.
Anagenics Limited has called a general meeting of shareholders for 29 January 2026 in Sydney to consider ratifying a recent equity placement to sophisticated investors. The board is seeking shareholder approval under ASX Listing Rule 7.4 for the prior issue of 74,448,054 fully paid ordinary shares at $0.0046 per share, completed on 22 December 2025, which, if ratified, will restore the company’s placement capacity and provide greater flexibility for future capital management while formalising the terms of the recent fundraising.
More about Anagenics
Anagenics Limited is an Australia-based company listed on the ASX, operating in the life sciences and health-focused consumer products sector. The company engages with sophisticated investors through equity placements to support its ongoing activities and capital needs within its specialised market niche.
Current Market Cap: A$2.48M
For an in-depth examination of AN1 stock, go to TipRanks’ Overview page.